Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	18.42	54.29	45.84
Graham Fair Price	-74.51	0.17	0.65
PEG	-1341.12	-5.45	-0.38
Price/Book	-14.06	1.86	2.16
Price/Cash Flow	7.00	220.51	206.08
Prices/Earnings	1224.65	511.05	38.58
Price/Sales	-18.59	0.66	0.81
Price/FCF	7.00	220.51	206.08
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-6.75	0.10	0.10
Operating Margin	-28.45	0.01	0.02
ROA	-93.32	< 0.005	< 0.005
ROE	0.01	< 0.005	-93.51
ROIC	< 0.005	< 0.005	-32.84
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.03	< 0.005	-6908.17
Dividends QOQ	-0.18	0.05	-73.02
EBIT QOQ	1.07	-0.24	-77.13
EPS QOQ	1.02	-0.94	-8.08
FCF QOQ	1.05	-0.20	-81.34
Revenue QOQ	0.04	0.06	41.53
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	43.04	40.82	-5.17
Days Sales Outstanding (DSO)	209.38	213.75	2.09
Inventory Turnover	2.09	2.20	5.45
Debt/Capitalization	0.79	0.78	-0.65
Quick Ratio	0.81	0.91	12.53
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	1.16	1.61	39.54
Cash	1.49	1.57	4.92
Capex	< 0.005	0.01	39.06
Free Cash Flow	0.01	< 0.005	-19.63
Revenue	3.07	3.25	5.63
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.04	1.04	0.49
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	24.60	30.14	22.48
Naive Interpretation	Member

06 - Financial Health · Bad

Rating